The use of AI in pharmaceutical development is becoming widespread, but the rulebook is still being written.McKinsey reports that 71% of businesses across various industries now use generative AI, ...

AI: How does this technological revolution fit with the pharmaceutical regulators who oversee the pharmaceutical sector at ...

AI is reshaping the life sciences industry in ways that are no longer hypothetical. The question is no longer whether to ...

Amendment reduces and simplifies royalty structure on Teverelix ® from ~4% to 2% while preserving global rights and IP control The Company is ...

Glaucoma has long been treated as a plumbing problem of the eye, managed mainly by lowering pressure rather than protecting ...

Find a portion of our conversation below, which covers Broussard’s decision to leave Humana and his thoughts on how AI could affect health care companies’ brand reputations. Editor’s Note: Transcript ...

The "MBA Strategic Thinking for Pharma and Biopharma Professionals Training Course (Feb 23rd - Feb 24th, 2026)" training has been added to ResearchAndMarkets.com's offering. Working in the highly ...

Change is often presented as an enigma. Unlike a traditional management task, you can’t just devise a plan and execute it. To be an effective change leader, you need to embrace a certain amount of ...

While Gemini 3 is still making waves, Google's not taking the foot off the gas in terms of releasing new models. Yesterday, the company released FunctionGemma, a specialized 270-million parameter AI ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.